Hypercoagulable States: A Review
Authors:
- 1 March 2005
- journal article
- review article
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 39 (2) , 123-133
Abstract
Vascular surgeons are often asked to evaluate patients with recurrent thromboses or thromboses in unusual locations either arterial or venous. There may be obvious inciting factors, but in many of these patients the possibility of a previously undiagnosed hypercoagulable state must be considered. Hypercoagulable states can be acquired (smoking, medication, change in physiologic status as occurs with pregnancy) or congenital. Congenital hypercoagulable disorders are more prevalent in families or patients with a history of thromboembolic events early in life or multiple miscarriages and include conditions such as protein C or S deficiencies, factor V Leiden mutation, and prothrombin gene variant. This article reviews the hypercoagulable states that are encountered in clinical practice as well as guidelines for testing and goals of therapy.Keywords
This publication has 47 references indexed in Scilit:
- Protein C, Antithrombin, and Venous Thromboembolism IncidenceArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Genetic Susceptibility to Venous ThrombosisNew England Journal of Medicine, 2001
- Prothrombin G20210A Polymorphism and ThrombophiliaMayo Clinic Proceedings, 2000
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C ResistanceArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Do patients with the heparin-induced thrombocytopenia syndrome have heparin-specific antibodies?Journal of Vascular Surgery, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Warfarin skin necrosis treated with prostacyclinClinical and Experimental Dermatology, 1987
- The Regulation of Hemostasis: The Protein C SystemNew England Journal of Medicine, 1986
- EFFICACY OF LOW-DOSE HEPARIN IN PREVENTION OF EXTENSIVE DEEP-VEIN THROMBOSIS IN PATIENTS UNDERGOING TOTAL-HIP REPLACEMENTThe Lancet, 1976